105 related articles for article (PubMed ID: 8072203)
1. Immunoblastic lymphadenopathy in a five-month-old girl: successful treatment with immunosuppressants.
Hirose M; Sano T; Takahashi Y; Okamoto Y; Ushiroguchi Y; Watanabe T; Ninomiya T; Kuroda Y
Jpn J Clin Oncol; 1994 Aug; 24(4):228-32. PubMed ID: 8072203
[TBL] [Abstract][Full Text] [Related]
2. Splenectomy for treatment of immunoblastic lymphadenopathy.
Hirose M; Nakagawa R; Okada A; Sano T; Kuroda Y
Br J Haematol; 1994 Jul; 87(3):661-2. PubMed ID: 7993817
[TBL] [Abstract][Full Text] [Related]
3. [Biclonal gammopathy in a patient with immunoblastic lymphadenopathy like T cell lymphoma].
Murakami M; Sugiura K
Rinsho Ketsueki; 1989 Jan; 30(1):116-21. PubMed ID: 2497263
[TBL] [Abstract][Full Text] [Related]
4. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): response to methotrexate and mercaptopurine.
Horneff G; Jürgens H; Hort W; Karitzky D; Göbel U
Med Pediatr Oncol; 1996 Sep; 27(3):187-92. PubMed ID: 8699998
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined methotrexate and prednisone.
Gerlando Q; Barbera V; Ammatuna E; Franco V; Florena AM; Mariani G
Haematologica; 2000 Aug; 85(8):880-1. PubMed ID: 10942945
[No Abstract] [Full Text] [Related]
6. Angioimmunoblastic lymphadenopathy.
Su WP
Dermatol Clin; 1985 Oct; 3(4):759-68. PubMed ID: 3916179
[TBL] [Abstract][Full Text] [Related]
7. [A remarkable effect of alpha-interferon in a case of angioimmunoblastic lymphadenopathy with dysproteinaemia (AILD) refractory to steroids and combination chemotherapies].
Imoto S; Ito M; Nakagawa T
Rinsho Ketsueki; 1991 Jun; 32(6):681-5. PubMed ID: 1890746
[TBL] [Abstract][Full Text] [Related]
8. Angio-immunoblastic lymphadenopathy. Report of a case with pleural effusion.
Mertelli MF; Rambotti P; Velardi A; Aversa F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(3):306-11. PubMed ID: 80357
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of IBL-like T-cell lymphoma with cyclosporin A: two case reports with special reference to serum cytokine levels.
Takemori N; Kodaira J; Sato T; Sakurai H; Akakura N; Kimura S; Katagiri M
Hum Cell; 2000 Mar; 13(1):35-42. PubMed ID: 10937345
[TBL] [Abstract][Full Text] [Related]
10. Myelodysplastic syndrome associated with immunoblastic lymphadenopathy-like T-cell lymphoma: simultaneous clinical improvement with chemotherapy.
Anzai T; Hirose W; Nakane H; Kawagoe M; Kawai T; Watanabe K
Jpn J Clin Oncol; 1994 Apr; 24(2):106-10. PubMed ID: 8158857
[TBL] [Abstract][Full Text] [Related]
11. [IBL-type lymphadenopathy after infection of rubella virus].
Kondo H; Okagawa K; Takeichi T; Hayashi T; Kawauchi Y; Saito S; Sano T; Kagawa N; Shirakami A
Rinsho Ketsueki; 1991 Sep; 32(9):976-80. PubMed ID: 1719258
[TBL] [Abstract][Full Text] [Related]
12. [Angioimmunoblastic lymphadenopathy with cutaneous manifestations in a 13-year-old girl].
Schotte U; Megahed M; Jansen T; Rübo J; Vandieken R; Goerz G; Plewig G
Hautarzt; 1992 Nov; 43(11):728-34. PubMed ID: 1281812
[TBL] [Abstract][Full Text] [Related]
13. Cell dynamics and expression of tumor necrosis factor (TNF)-alpha, interleukin-6, and TNF receptors in angioimmunoblastic lymphadenopathy-type T cell lymphoma.
Yamaguchi S; Kitagawa M; Inoue M; Tomizawa N; Kamiyama R; Hirokawa K
Exp Mol Pathol; 2000 Apr; 68(2):85-94. PubMed ID: 10716912
[TBL] [Abstract][Full Text] [Related]
14. Angioimmunoblastic lymphadenopathy: an etiology for gastrointestinal lymphomatous polyposis.
Goenka MK; Vaiphei K; Nagi B; Sriram PV; Joshi K; Kochhar R
Am J Gastroenterol; 1996 Jun; 91(6):1236-8. PubMed ID: 8651178
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
Egan LJ; Sandborn WJ; Tremaine WJ
Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
[TBL] [Abstract][Full Text] [Related]
16. [Angioimmunoblastic T-cell lymphoma complicated by recurrent drug-induced agranulocytosis].
Inoue D; Kimura T; Shimoji S; Mori M; Nagai Y; Tabata S; Kurata M; Matsushita A; Nagai K; Maruoka H; Yamashita E; Takahashi T
Rinsho Ketsueki; 2009 Feb; 50(2):87-91. PubMed ID: 19265300
[TBL] [Abstract][Full Text] [Related]
17. Immunoblastic lymphadenopathy: case report and literature review.
Cooperberg AA; de Champlain MB; Siminovitch J; Rosenberg A; Schwartz JP
Can Med Assoc J; 1977 Jul; 117(1):53-7. PubMed ID: 861911
[TBL] [Abstract][Full Text] [Related]
18. Angioimmunoblastic lymphadenopathy (AILD) with benign course.
Mihaljević B; Donfrid M; Jancić-Nedeljkov R; Jovanović V; Petrović M
Haematologia (Budap); 1996; 28(1):21-5. PubMed ID: 9283900
[TBL] [Abstract][Full Text] [Related]
19. Immunoblastic lymphadenopathy (IBL)-like T-cell lymphoma in a child.
Nakazono S; Kitahara T; Takezaki T; Kawakami K; Hasui K; Satoh E; Tokunaga M
Acta Paediatr Jpn; 1991 Jun; 33(3):398-407. PubMed ID: 1785338
[TBL] [Abstract][Full Text] [Related]
20. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
